This may be attributed to the dysregulated immunological status and the exaggerated pro-inflammatory cytokine response, manifesting as higher ratios of lymphopenia and increased levels of neutrophils, serum CRP, and IL-6 in patients with COVID-19 with pre-existing T2D compared to non-diabetic patients (19, 23). This evidence concerns the gene IL6 and COVID-19.